Organon & Co (OGN)
- Exchange
- NYSE
- Symbol
- OGN
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.
- Country
- USA
Stock price
At close: November 6, 2024
-
Open16.75
-
High16.82
-
Low15.74
-
Close15.80
-
Volume5,394,780
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
3.49
Receivables turnover
3.59
Payables turnover
3.49
Working capital turnover
3.94
Days of inventory on hand (DOH)
104.66
Days of sales outstanding (DSO)
101.64
Number of days of payables
104.58
Fixed asset turnover
5.29
Total asset turnover
0.52
Current ratio
1.54
Quick ratio
0.84
Cash ratio
0.24
Cash conversion cycle
101.72
Debt-to-assets ratio
0.73
Debt-to-capital ratio
1.01
Debt-to-equity ratio
—
Financial leverage ratio
—
Interest coverage
2.28
Gross profit margin
26.78%
Operating profit margin
-14.85%
Pretax margin
10.75%
Net profit margin
16.33%
Operating return on assets (Operating ROA)
-7.71%
Return on assets (ROA)
8.48%
Return on total capital
13.82%
Return on equity (ROE)
—